POM-V Prescription Required Companion Animal

Tilmovet 40 g/kg Premix for Medicated Feeding Stuff for Pigs and Rabbits

Active ingredient: Tilmicosin

Form

Premix

Species

Pigs Rabbits

Manufacturer

Huvepharma NV

VMD MA No.

30282/5024

What it's used for

AN: 04025/2023 and 04026/2023

Full indications, dosage and side effects ↓

View official SPC (PDF)

The prescription itself has a price. See what practices near you charge for a consultation and the written prescription fee.

Paying less for Tilmicosin

1

Ask your vet for a written prescription

They must provide one on request. Under the CMA Order the fee is capped at £21 from 2027.
2

Fill it at a registered online retailer

The CMA found online pharmacies 50–60% cheaper than practice dispensing on common medicines — typically £200–£300 a year.

Your prescription rights → VMD register of retailers →

Prescription required

Your vet must provide a written prescription on request. You can then purchase from any licensed online retailer.

Clinical information

Tilmovet 40 g/kg Premix for Medicated Feeding Stuff for Pigs and Rabbits — SPC Details

Source: VMD Summary of Product Characteristics (SPC). Last updated 27 Mar 2026.

AN: 04025/2023 and 04026/2023

The intake of medicated feed depends on the clinical condition of the animals. In
order to obtain the correct dosage the concentration of tilmicosin may need to be
adjusted accordingly.
Use the following formula:
Kg veterinary medicinal product = Dose rate (mg/kg bodyweight) x bodyweight (kg)
tonne feed Daily feed intake (kg) x premix strength (g/kg)
Pigs
Administer in the feed at a dose of 8 to 16 mg/kg body weight/day of tilmicosin
(equivalent to 200 to 400 ppm in the feed) for a period of 15 to 21 days.
IndicationDose of tilmicosinDuration of
treatment
Inclusion rate in
feed
Treatment and
metaphylaxis of
respiratory
disease
8-16 mg/kg
bodyweight/day
15 to 21 days5-10 kg veterinary
medicinal
product/tonne
Rabbits
Administer in the feed at 12 mg/kg body weight/day of tilmicosin (equivalent to 200
ppm in the feed) for 7 days.
IndicationDose of tilmicosinDuration of
treatment
Inclusion rate in
feed
Treatment and
metaphylaxis of
respiratory
disease
12 mg/kg
bodyweight/day
7 days5 kg veterinary
medicinal product
/tonne
To ensure thorough dispersion of the veterinary medicinal product, it should first be
mixed with a suitable quantity of feed before incorporation into the finished feed.
This veterinary medicinal product can be incorporated into pelleted feed,
preconditioned for the minimum time-period at a temperature not exceeding 75°C.
AN: 04025/2023 and 04026/2023

Tilmicosin is known to be toxic for horses. Do not allow horses or other equines
access to feeds containing tilmicosin. Horses or other Equidae, must not be allowed
access to feeds containing tilmicosin. Horses fed with tilmicosin medicated feeds
may present signs of toxicity with lethargy, anorexia, reduction of feed consumption,
loose stools, colic, distension of the abdomen and death.
Do not use in cases of hypersensitivity to the active substance or to any of the
excipients.

Pigs and rabbits:
Very rare
(<1 animal / 10,000 animals
treated, including isolated
report(s)):
Reduced food intake, food refusal
1
this effect is transient
Reporting adverse events is important. It allows continuous safety monitoring of a
veterinary medicinal product. Reports should be sent, preferably via a veterinarian,
to either the marketing authorisation holder or its local representative or the national
competent authority via the national reporting system. See the package leaflet for
respective contact details.

With regard to the management of respiratory disease outbreaks, it should be noted
that acutely ill animals are likely to be inappetant and therefore require parenteral
treatment.
Repeated use of the veterinary medicinal product should be avoided by improving
management practices and thorough cleansing and disinfection.
Cross-resistance has been shown between tilmicosin and other macrolides (like
tylosin, erythromycin) or lincomycin. Use of the veterinary medicinal product should
be carefully considered when susceptibility testing has shown resistance to other
macrolides or lincosamides because its effectiveness may be reduced.

Special precautions for safe use in the target species:
Due to the likely variability (time, geographical) in the occurrence of the resistance of
bacteria for tilmicosin, bacteriological sampling and susceptibility testing are
recommended.
Use of the veterinary medicinal product should be based on identification and
susceptibility testing of the target pathogen(s). If this is not possible, therapy should
be based on epidemiological information and knowledge of susceptibility of the target
pathogens at farm level, or at local/regional level.
Use of the veterinary medicinal product should be in accordance with official,
national and regional antimicrobial policies.
Inappropriate use of the veterinary medicinal product may increase the prevalence of
bacteria resistant to tilmicosin and may decrease the effectiveness of treatment with
tilmicosin related substances.
An antibiotic with a lower risk of antimicrobial resistance selection (lower AMEG
category) should be used for first line treatment where susceptibility testing suggests
the likely efficacy of this approach.
Do not use for prophylaxis.
AN: 04025/2023 and 04026/2023
Special precautions to be taken by the person administering the veterinary medicinal
product to animals
People with known hypersensitivity to tilmicosin should avoid contact with the
veterinary medicinal product.
May cause sensitisation by skin contact. May cause skin and eye irritation. Avoid
direct skin contact. Personal protective equipment consisting of overalls, safety
glasses and impervious gloves should be worn when handling the veterinary
medicinal product. Wash affected parts if skin contact occurs. If accidental eye
contact occurs, immediately rinse thoroughly with water. In case of accidental
ingestion, or if you develop symptoms following exposure such as skin rash, seek
medical advice immediately and show the package leaflet or the label to the
physician. Swelling of the face, lips or eyes or difficulty with breathing are more
serious symptoms and require urgent medical attention.
If the operations involve the risk of exposure to dust, wear either a disposable filter
and half mask respirator conforming to European Standard EN149 or a non-
disposable respirator to European Standard EN140 fitted with a filter to EN143. This
warning is particularly relevant to on-farm mixing, where the risk of exposure to dust
is likely to be enhanced.
Special precautions for the protection of the environment:
Not applicable.

Do not use simultaneously with other macrolides and lincosamides.
Do not use simultaneously with bacteriostatic antimicrobial agents.
Tilmicosin may decrease the antibacterial activity of β-lactam antibiotics.

Do not store above 30°C.
Store in the original container.
Store in a dry place.

Pigs: meat and offal: 21 days
Rabbits: meat and offal: 4 days

This information is sourced from the official Summary of Product Characteristics (SPC) published by the Veterinary Medicines Directorate (VMD). It is provided for informational purposes only and does not replace professional veterinary advice. Always consult your vet before administering any medication.